HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prosidion Ltd.

http://www.prosidion.com

Latest From Prosidion Ltd.

Financings Of The Fortnight: Why Are Royalty-Based Financings On The Rise Again?

Plus news on recent financings by Vivus, Novira Therapeutics, Theraclone Sciences and Receptos.

Business Strategies

To Fill Pipeline Gaps, Astellas Narrows Focus And Takeda Spreads A Wider Net: Japan Earnings Roundup

PharmAsia News takes a closer look at pipeline updates from Japan’s two largest pharma companies.

BioPharmaceutical Japan

To Fill Pipeline Gaps, Astellas Narrows Focus And Takeda Spreads A Wider Net: Japan Earnings Roundup (Part 1)

In part one of this roundup of the Japanese pharma earnings season, PharmAsia News takes a closer look at the pipeline updates from the country's two largest pharma companies.

BioPharmaceutical Japan

Deals Shaping The Medical Industry (01/2012)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register